KEMET Reports Preliminary Fourth Quarter and Fiscal Year 2014 Results
GREENVILLE, S.C., May 8, 2014 /PRNewswire/ -- KEMET Corporation (the "Company") (NYSE: KEM), a leading global supplier of electronic components, today reported preliminary results for the fourth quarter and fiscal year ended March 31, 2014. Results included in this earnings release have been adjusted to reflect discontinued operations as the Film and Electrolytic Business group completed the sale of its machinery division on April 30, 2014.
Net sales of $215.8 million for the quarter ended March 31, 2014 increased 4.1% from net sales of $207.3 million for the prior quarter ended December 31, 2013, and increased 8.2% compared to net sales of $199.5 million for the quarter ended March 31, 2013. For the fiscal year ended March 31, 2014 net sales were $833.7 million compared to $823.9 million for the fiscal year ended March 31, 2013.
"We are encouraged by the continued and growing strength of our markets around the globe," stated Per Loof, KEMET's Chief Executive Officer. "Revenue exceeded our expectations, cost reduction actions are seeing their way to the bottom line, and we are well positioned to continue improving our financial performance into our next fiscal year. While we have some more work to complete, we are pleased with the general improvement of our operating margins this past fiscal year and we plan to build upon our efforts this past year to improve them further," continued Loof.
The U.S. GAAP net loss from continuing operations was $15.2 million, or $0.34 loss per basic and diluted share for the quarter ended March 31, 2014, compared to a net loss from continuing operations of $23.7 million or $0.53 loss per basic and diluted share for the quarter ended March 31, 2013. For the fiscal year ended March 31, 2014, the net loss from continuing operations was $65.5 million, or $1.45 per basic and diluted share compared a net loss from continuing operations of $77.9 million, or $1.74 per basic and diluted share for the fiscal year ended March 31, 2013.
Non-U.S. GAAP Adjusted net income improved to $0.4 million or $0.01 per diluted share for the quarter ended March 31, 2014, compared to a non-U.S. GAAP Adjusted net loss of $8.3 million or $0.18 loss per basic and diluted share for the period ended March 31, 2013. For the fiscal year ended March 31, 2014, the non-U.S. GAAP net loss from continuing operations was $18.8 million, or $0.42 loss per basic and diluted share compared to a net loss from continuing operations of $23.2 million, or $0.51 loss per basic and diluted share for the fiscal year ended March 31, 2013.
The net loss for the quarters ended March 31, 2014 and 2013 include various items affecting comparability as denoted in the U.S. GAAP to Non-U.S. GAAP reconciliation table included hereafter.
About KEMET
The Company's common stock is listed on the NYSE under the ticker symbol "KEM" (NYSE: KEM). At the Investor Relations section of our web site at http://www.kemet.com/IR, users may subscribe to KEMET news releases and find additional information about our Company. KEMET applies world class service and quality to deliver industry leading, high performance capacitance solutions to its customers around the world and offers the world's most complete line of surface mount and through hole capacitor technologies across tantalum, ceramic, film, aluminum, electrolytic, and paper dielectrics. Additional information about KEMET can be found at http://www.kemet.com.
QUIET PERIOD
Beginning July 1, 2014, we will observe a quiet period during which the information provided in this news release and annual report on Form 10-K will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS
Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates," variations of such words and other similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.
Factors that may cause actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) continued net losses could impact our ability to realize current operating plans and could materially adversely affect our liquidity and our ability to continue to operate; (iii) adverse economic conditions could cause the write down of long-lived assets or goodwill; (iv) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased materials; (v) changes in the competitive environment; (vi) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vii) economic, political, or regulatory changes in the countries in which we operate; (viii) difficulties, delays or unexpected costs in completing the restructuring plan; (ix) equity method investments expose us to a variety of risks; (x) acquisitions and other strategic transactions expose us to a variety of risks; (xi) inability to attract, train and retain effective employees and management; (xii) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xiii) exposure to claims alleging product defects; (xiv) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xv) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xvi) volatility of financial and credit markets affecting our access to capital; (xvii) the need to reduce the total costs of our products to remain competitive; (xviii) potential limitation on the use of net operating losses to offset possible future taxable income; (xix) restrictions in our debt agreements that limit our flexibility in operating our business; and (xx) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions.
KEMET CORPORATION AND SUBSIDIARIES Consolidated Statements of Operations (Amounts in thousands, except per share data) (Unaudited)
|
|||||||||||||||
Quarters Ended March 31, |
Fiscal Year Ended |
||||||||||||||
2014 |
2013 |
2014 |
2013 |
||||||||||||
Net sales |
$ |
215,821 |
$ |
199,540 |
$ |
833,666 |
$ |
823,903 |
|||||||
Operating costs and expenses: |
|||||||||||||||
Cost of sales |
181,315 |
171,342 |
712,037 |
697,076 |
|||||||||||
Selling, general and administrative expenses |
24,055 |
30,501 |
94,881 |
107,620 |
|||||||||||
Research and development |
6,763 |
6,693 |
24,466 |
26,876 |
|||||||||||
Restructuring charges |
5,953 |
5,047 |
14,122 |
18,719 |
|||||||||||
Goodwill impairment |
— |
— |
— |
1,092 |
|||||||||||
Write down of long-lived assets |
1,118 |
264 |
4,476 |
7,582 |
|||||||||||
Net (gain) loss on sales and disposals of assets |
(39) |
141 |
32 |
18 |
|||||||||||
Total operating costs and expenses |
219,165 |
213,988 |
850,014 |
858,983 |
|||||||||||
Operating loss |
(3,344) |
(14,448) |
(16,348) |
(35,080) |
|||||||||||
Other (income) expense: |
|||||||||||||||
Interest income |
(13) |
(28) |
(195) |
(139) |
|||||||||||
Interest expense |
10,671 |
10,491 |
40,962 |
41,331 |
|||||||||||
Other income, net |
(2,632) |
(1,738) |
(2,681) |
(2,864) |
|||||||||||
Loss from continuing operations before income taxes and equity loss from NEC TOKIN |
(11,370) |
(23,173) |
(54,434) |
(73,408) |
|||||||||||
Income tax expense (benefit) |
(754) |
(735) |
3,539 |
3,269 |
|||||||||||
Loss from continuing operations before equity loss from NEC TOKIN |
(10,616) |
(22,438) |
(57,973) |
(76,677) |
|||||||||||
Equity loss from NEC TOKIN |
(4,580) |
(1,254) |
(7,542) |
(1,254) |
|||||||||||
Loss from continuing operations |
(15,196) |
(23,692) |
(65,515) |
(77,931) |
|||||||||||
Loss from discontinued operations |
(63) |
(1,559) |
(3,800) |
(4,251) |
|||||||||||
Net loss |
$ |
(15,259) |
$ |
(25,251) |
$ |
(69,315) |
$ |
(82,182) |
|||||||
Net loss per basic and diluted share: |
|||||||||||||||
Loss from continuing operations |
$ |
(0.34) |
$ |
(0.53) |
$ |
(1.45) |
$ |
(1.74) |
|||||||
Loss from discontinued operations |
$ |
— |
$ |
(0.03) |
$ |
(0.08) |
$ |
(0.09) |
|||||||
Net loss |
$ |
(0.34) |
$ |
(0.56) |
$ |
(1.54) |
$ |
(1.83) |
|||||||
Weighted-average shares outstanding: |
|||||||||||||||
Basic and diluted |
45,174 |
44,953 |
45,102 |
44,897 |
KEMET CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (Amounts in thousands, except per share data)
|
|||||||
March 31, 2014 |
March 31, 2013 |
||||||
(Unaudited) |
|||||||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
57,929 |
$ |
95,978 |
|||
Accounts receivable, net |
98,947 |
93,774 |
|||||
Inventories, net |
187,784 |
198,888 |
|||||
Prepaid expenses and other |
36,871 |
41,101 |
|||||
Deferred income taxes |
6,681 |
4,167 |
|||||
Current assets of discontinued operations |
12,160 |
9,517 |
|||||
Total current assets |
400,372 |
443,425 |
|||||
Property and equipment |
292,648 |
303,682 |
|||||
Goodwill |
35,584 |
35,584 |
|||||
Intangible assets, net |
37,184 |
38,646 |
|||||
Investment in NEC TOKIN |
45,970 |
52,738 |
|||||
Restricted cash |
13,512 |
17,397 |
|||||
Deferred income taxes |
6,778 |
7,994 |
|||||
Other assets |
10,130 |
10,149 |
|||||
Noncurrent assets of discontinued operations |
836 |
1,976 |
|||||
Total assets |
$ |
843,014 |
$ |
911,591 |
|||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||
Current liabilities: |
|||||||
Current portion of long-term debt |
$ |
7,297 |
$ |
10,793 |
|||
Accounts payable |
73,370 |
70,774 |
|||||
Accrued expenses |
75,868 |
93,178 |
|||||
Income taxes payable and deferred income taxes |
1,342 |
1,074 |
|||||
Current liabilities of discontinued operations |
7,269 |
5,661 |
|||||
Total current liabilities |
165,146 |
181,480 |
|||||
Long-term debt, less current portion |
391,292 |
372,707 |
|||||
Other non-current obligations |
55,864 |
69,022 |
|||||
Deferred income taxes |
5,189 |
8,542 |
|||||
Noncurrent liabilities of discontinued operations |
2,592 |
2,924 |
|||||
Commitments and contingencies |
|||||||
Stockholders' equity: |
|||||||
Preferred stock, par value $0.01, authorized 10,000 shares, none issued |
— |
— |
|||||
Common stock, par value $0.01, authorized 175,000 shares, issued 46,508 shares at March 31, 2014 and March 31, 2013 |
465 |
465 |
|||||
Additional paid-in capital |
465,026 |
467,096 |
|||||
Retained deficit |
(232,550) |
(163,235) |
|||||
Accumulated other comprehensive income |
20,044 |
7,694 |
|||||
Treasury stock, at cost (1,301 and 1,519 shares at March 31, 2014 and March 31, 2013, respectively) |
(30,054) |
(35,104) |
|||||
Total stockholders' equity |
222,931 |
276,916 |
|||||
Total liabilities and stockholders' equity |
$ |
843,014 |
$ |
911,591 |
KEMET CORPORATION AND SUBSIDIARIES Consolidated Statements of Cash Flows (Amounts in thousands) (Unaudited)
|
|||||||
Fiscal Years Ended March 31, |
|||||||
2014 |
2013 |
||||||
Net loss |
$ |
(69,315) |
$ |
(82,182) |
|||
Adjustments to reconcile net loss to net cash provided by operating activities: |
|||||||
Net cash provided by operating activities of discontinued operations |
29 |
4,440 |
|||||
Depreciation and amortization |
49,842 |
45,559 |
|||||
Amortization of debt discount and debt issuance costs |
3,596 |
4,138 |
|||||
Equity loss from NEC TOKIN |
7,542 |
1,254 |
|||||
Change in value of NEC TOKIN options |
(3,111) |
— |
|||||
Net loss on sales and disposals of assets |
32 |
18 |
|||||
Stock-based compensation expense |
2,909 |
4,599 |
|||||
Pension and other post-retirement benefits |
(78) |
1,071 |
|||||
Deferred income taxes |
(4,676) |
(317) |
|||||
Write down of long-lived assets |
4,476 |
7,582 |
|||||
Write down of receivables |
1,484 |
— |
|||||
Goodwill impairment |
— |
1,092 |
|||||
Other, net |
(372) |
554 |
|||||
Changes in assets and liabilities: |
|||||||
Accounts receivable |
(4,618) |
4,882 |
|||||
Inventories |
14,921 |
(324) |
|||||
Prepaid expenses and other current assets |
3,748 |
(11,151) |
|||||
Accounts payable |
(3,523) |
300 |
|||||
Accrued income taxes |
535 |
(1,052) |
|||||
Other operating liabilities |
(8,346) |
(3,290) |
|||||
Net cash used in operating activities |
(4,925) |
(22,827) |
|||||
Investing activities: |
|||||||
Capital expenditures |
(32,147) |
(46,174) |
|||||
Investment in NEC TOKIN |
— |
(50,917) |
|||||
Change in restricted cash |
4,047 |
(15,284) |
|||||
Proceeds from sales of assets |
1,026 |
398 |
|||||
Net cash used in investing activities |
(27,074) |
(111,977) |
|||||
Financing activities: |
|||||||
Proceeds from revolving line of credit |
21,000 |
— |
|||||
Payment of revolving line of credit |
(2,551) |
— |
|||||
Deferred acquisition payments |
(21,977) |
(16,900) |
|||||
Proceeds from issuance of debt |
— |
39,825 |
|||||
Payments of long-term debt |
(3,599) |
(1,909) |
|||||
Proceeds from exercise of stock options |
250 |
111 |
|||||
Debt issuance costs |
— |
(275) |
|||||
Net cash (used in) provided by financing activities |
(6,877) |
20,852 |
|||||
Net decrease in cash and cash equivalents |
(38,876) |
(113,952) |
|||||
Effect of foreign currency fluctuations on cash |
827 |
(591) |
|||||
Cash and cash equivalents at beginning of fiscal period |
95,978 |
210,521 |
|||||
Cash and cash equivalents at end of fiscal period |
$ |
57,929 |
$ |
95,978 |
Non-U.S. GAAP Financial Measures
In this news release, the Company makes reference to certain Non-U.S. GAAP financial measures, including "Adjusted gross margin", "Adjusted net loss", "Adjusted net loss per share" and "Adjusted EBITDA". Management believes that investors may find it useful to review the Company's financial results as adjusted to exclude items as determined by management.
Adjusted gross margin
Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided below. Management uses Adjusted gross margin to facilitate our analysis and understanding of our business operations and believes that Adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with U.S. GAAP.
The following table provides reconciliation from U.S. GAAP Gross margin to Non-U.S. GAAP Adjusted gross margin (amounts in thousands):
Quarters Ended |
Fiscal Years Ended |
||||||||||||||||||
March 31, 2014 |
December 31, 2013 |
March 31, 2013 |
March 31, 2014 |
March 31, 2013 |
|||||||||||||||
(Unaudited) |
|||||||||||||||||||
Net sales |
$ |
215,821 |
$ |
207,339 |
$ |
199,540 |
$ |
833,666 |
$ |
823,903 |
|||||||||
Gross margin |
34,506 |
37,662 |
28,198 |
121,629 |
126,827 |
||||||||||||||
Non-U.S. GAAP-adjustments: |
|||||||||||||||||||
Plant shut-down costs |
2,668 |
— |
— |
2,668 |
— |
||||||||||||||
Plant start-up costs |
669 |
485 |
1,307 |
3,336 |
6,122 |
||||||||||||||
Stock-based compensation expense |
186 |
278 |
373 |
1,006 |
1,554 |
||||||||||||||
Inventory write-down |
— |
— |
— |
3,886 |
— |
||||||||||||||
Adjusted gross margin |
$ |
38,029 |
$ |
38,425 |
$ |
29,878 |
$ |
132,525 |
$ |
134,503 |
|||||||||
17.6 |
% |
18.5 |
% |
15.0 |
% |
15.9 |
% |
16.3 |
% |
Adjusted Operating Income
Adjusted operating loss represents operating income, excluding adjustments which are outlined in the quantitative reconciliation provided above. We use Adjusted operating loss to facilitate our analysis and understanding of our business operations and believe that Adjusted operating loss is useful to investors because it provides a supplemental way to understand our underlying operating performance. Adjusted operating loss should not be considered as an alternative to operating income or any other performance measure derived in accordance with U.S. GAAP.
Adjusted operating income is calculated as follows (amounts in thousands):
Quarters Ended |
|||||||||||
March 31, 2014 |
December 31, 2013 |
March 31, 2013 |
|||||||||
(Unaudited) |
|||||||||||
Operating income (loss) |
$ |
(3,344) |
$ |
3,623 |
$ |
(14,448) |
|||||
Adjustments: |
|||||||||||
Restructuring charges |
5,953 |
2,194 |
5,047 |
||||||||
Plant shut-down costs |
2,668 |
— |
— |
||||||||
Write down of long-lived assets |
1,118 |
3,358 |
— |
||||||||
ERP integration costs |
837 |
994 |
2,404 |
||||||||
Plant start-up costs |
669 |
485 |
1,307 |
||||||||
NEC TOKIN investment related expenses |
618 |
249 |
3,009 |
||||||||
Stock-based compensation expense |
579 |
702 |
1,018 |
||||||||
Net loss (gain) on sales and disposals of assets |
(39) |
29 |
141 |
||||||||
Net curtailment and settlement loss on benefit plans |
— |
— |
1,354 |
||||||||
Adjusted operating income (loss) |
$ |
9,059 |
$ |
11,634 |
$ |
(168) |
Adjusted Net Loss and Adjusted Net Loss Per Share
"Adjusted net loss" and "Adjusted net loss per share" represent net loss and net loss per share excluding adjustments which are outlined in the quantitative reconciliation provided below. Management believes that these Non-U.S. GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company. Management uses these Non-U.S. GAAP financial measures to evaluate operating performance. Non-U.S. GAAP financial measures should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.
The following table provides reconciliation from U.S. GAAP net loss to Non-U.S. GAAP adjusted net loss:
U.S. GAAP to Non- U.S. GAAP Reconciliation
|
||||||||||||||||
Fiscal Year Ended |
Quarters Ended |
|||||||||||||||
March 31, 2014 |
March 31, 2014 |
December 31, 2013 |
March 31, 2013 |
|||||||||||||
(Unaudited, Amounts in thousands, except per share data) |
||||||||||||||||
U.S. GAAP |
||||||||||||||||
Net sales |
$ |
833,666 |
$ |
215,821 |
$ |
207,339 |
$ |
199,540 |
||||||||
Net loss from continuing operations |
(65,515) |
(15,196) |
(4,746) |
(23,692) |
||||||||||||
Loss from discontinued operations |
(3,800) |
(63) |
(1,076) |
(1,559) |
||||||||||||
Net loss |
$ |
(69,315) |
$ |
(15,259) |
$ |
(5,822) |
$ |
(25,251) |
||||||||
Net loss from continuing operations - basic and diluted |
$ |
(1.45) |
$ |
(0.34) |
$ |
(0.11) |
$ |
(0.53) |
||||||||
Loss from discontinued operations - basic and diluted |
$ |
(0.08) |
$ |
— |
$ |
(0.02) |
$ |
(0.03) |
||||||||
Net loss - basic and diluted |
$ |
(1.54) |
$ |
(0.34) |
$ |
(0.13) |
$ |
(0.56) |
||||||||
Non-U.S. GAAP |
||||||||||||||||
Loss from continuing operations |
(65,515) |
(15,196) |
(4,746) |
(23,692) |
||||||||||||
Adjustments: |
||||||||||||||||
Restructuring charges |
14,122 |
5,953 |
2,194 |
5,047 |
||||||||||||
Equity loss (gain) from NEC TOKIN |
7,542 |
4,580 |
(1,657) |
1,254 |
||||||||||||
Write down of long-lived assets |
4,476 |
1,118 |
3,358 |
264 |
||||||||||||
Inventory write down |
3,886 |
— |
— |
— |
||||||||||||
ERP integration expenses |
3,880 |
837 |
994 |
2,404 |
||||||||||||
Amortization included in interest expense |
3,596 |
779 |
858 |
1,092 |
||||||||||||
Plant start-up costs |
3,336 |
669 |
485 |
1,307 |
||||||||||||
Stock-based compensation expense |
2,909 |
579 |
702 |
1,018 |
||||||||||||
Plant shut-down costs |
2,668 |
2,668 |
— |
— |
||||||||||||
Acquisition related fees |
2,299 |
618 |
249 |
3,009 |
||||||||||||
Note receivable write off |
1,444 |
— |
— |
— |
||||||||||||
Loss (gain) on sales and disposals of assets |
32 |
(39) |
29 |
141 |
||||||||||||
Income tax effect of non-GAAP adjustments (1) |
(27) |
99 |
(52) |
(591) |
||||||||||||
Net curtailment and settlement gain on benefit plans |
— |
— |
— |
1,354 |
||||||||||||
Intangible write down |
— |
— |
— |
|||||||||||||
Net foreign exchange loss (gain) |
(304) |
(449) |
207 |
(911) |
||||||||||||
Change in value of NEC TOKIN Option |
(3,111) |
(1,777) |
(1,716) |
— |
||||||||||||
Adjusted net income (loss) from continuing operations |
$ |
(18,767) |
$ |
439 |
$ |
905 |
$ |
(8,304) |
||||||||
Adjusted net income (loss) per basic share from continuing operations |
$ |
(0.42) |
$ |
0.01 |
$ |
0.02 |
$ |
(0.18) |
||||||||
Adjusted net income (loss) per diluted share from continuing operations |
$ |
(0.42) |
$ |
0.01 |
$ |
0.02 |
$ |
(0.18) |
||||||||
Weighted average shares outstanding: |
||||||||||||||||
Basic |
45,102 |
45,174 |
45,120 |
44,953 |
||||||||||||
Diluted |
45,102 |
52,524 |
52,494 |
44,953 |
(1) The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction. |
Adjusted EBITDA
Adjusted EBITDA from continuing operations represents net loss from continuing operations before net interest expense, income tax expense, and depreciation and amortization expense, adjusted to exclude certain item which are outlined in the quantitative reconciliation provided below. We use Adjusted EBITDA from continuing operations to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business. We present Adjusted EBITDA from continuing operations as a supplemental measure of our performance and ability to service debt. We also present Adjusted EBITDA from continuing operations because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.
We believe Adjusted EBITDA from continuing operations is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other adjustments to arrive at Adjusted EBITDA from continuing operations are excluded in order to better reflect our continuing operations.
In evaluating Adjusted EBITDA from continuing operations, you should be aware that in the future we may incur expenses similar to the adjustments noted below. Our presentation of Adjusted EBITDA from continuing operations should not be construed as an inference that our future results will be unaffected by these types of adjustments. Adjusted EBITDA from continuing operations is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.
Our Adjusted EBITDA from continuing operations measure has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:
- it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
- it does not reflect changes in, or cash requirements for, our working capital needs;
- it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA from continuing operations measure does not reflect any cash requirements for such replacements;
- it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
- it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;
- it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and
- other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.
Because of these limitations, Adjusted EBITDA from continuing operations should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA from continuing operations only supplementally.
The following table provides a reconciliation from U.S. GAAP net loss to Adjusted EBITDA from continuing operations (amounts in thousands):
Fiscal Year 2014 |
|||||||||||||||
Q1 |
Q2 |
Q3 |
Q4 |
Total |
|||||||||||
Net loss |
$ |
(35,138) |
$ |
(13,096) |
$ |
(5,822) |
$ |
(15,259) |
$ |
(69,315) |
|||||
Adjustments: |
|||||||||||||||
Income tax expense (benefit) |
1,816 |
1,444 |
1,033 |
(754) |
3,539 |
||||||||||
Interest expense, net |
9,870 |
9,897 |
10,342 |
10,658 |
40,767 |
||||||||||
Depreciation and amortization expense |
13,639 |
11,951 |
11,762 |
12,182 |
49,534 |
||||||||||
Restructuring charges |
4,611 |
1,364 |
2,194 |
5,953 |
14,122 |
||||||||||
Net loss from discontinued operations |
1,510 |
1,151 |
1,076 |
63 |
3,800 |
||||||||||
Write down of long lived assets |
— |
— |
3,358 |
1,118 |
4,476 |
||||||||||
ERP integration costs |
978 |
1,071 |
994 |
837 |
3,880 |
||||||||||
Plant start-up costs |
1,132 |
1,050 |
485 |
669 |
3,336 |
||||||||||
Plant shut-down costs |
— |
— |
— |
2,668 |
2,668 |
||||||||||
NEC TOKIN investment related expenses |
1,308 |
124 |
249 |
618 |
2,299 |
||||||||||
Stock-based compensation expense |
969 |
659 |
702 |
579 |
2,909 |
||||||||||
Loss (gain) on sales and disposals of assets |
— |
42 |
29 |
(39) |
32 |
||||||||||
Change in value of NEC TOKIN option |
— |
382 |
(1,716) |
(1,777) |
(3,111) |
||||||||||
Inventory write-down |
3,886 |
— |
— |
— |
3,886 |
||||||||||
Long-term receivable write down |
1,444 |
— |
— |
— |
1,444 |
||||||||||
Equity loss (gain) from NEC TOKIN |
3,376 |
1,243 |
(1,657) |
4,580 |
7,542 |
||||||||||
Net foreign exchange loss (gain) |
(577) |
515 |
207 |
(449) |
(304) |
||||||||||
Adjusted EBITDA |
$ |
8,824 |
$ |
17,797 |
$ |
23,236 |
$ |
21,647 |
$ |
71,504 |
|||||
Fiscal Year 2013 |
|||||||||||||||
Q1 |
Q2 |
Q3 |
Q4 |
Total |
|||||||||||
Net loss |
$ |
(17,754) |
$ |
(24,920) |
$ |
(14,257) |
$ |
(25,251) |
$ |
(82,182) |
|||||
Adjustments: |
|||||||||||||||
Income tax expense (benefit) |
1,736 |
1,657 |
611 |
(735) |
3,269 |
||||||||||
Interest expense, net |
10,427 |
10,109 |
10,193 |
10,464 |
41,193 |
||||||||||
Depreciation and amortization expense |
11,558 |
11,426 |
10,405 |
11,781 |
45,170 |
||||||||||
Net (income) loss from discontinued operations |
(278) |
1,313 |
1,657 |
1,559 |
4,251 |
||||||||||
Restructuring charges |
1,264 |
8,522 |
3,886 |
5,047 |
18,719 |
||||||||||
Write down of long lived assets |
— |
4,234 |
3,083 |
264 |
7,582 |
||||||||||
ERP integration costs |
1,601 |
2,018 |
1,375 |
2,404 |
7,398 |
||||||||||
Plant start-up costs |
1,361 |
1,930 |
1,524 |
1,307 |
6,122 |
||||||||||
NEC TOKIN investment related expenses |
542 |
866 |
164 |
3,009 |
4,581 |
||||||||||
Stock-based compensation expense |
1,262 |
1,242 |
1,078 |
1,018 |
4,600 |
||||||||||
Goodwill impairment |
— |
1,092 |
— |
— |
1,092 |
||||||||||
Loss (gain) on sales and disposals of assets |
104 |
(31) |
(196) |
141 |
18 |
||||||||||
Net curtailment and settlement gain on benefit plans |
— |
(1,675) |
588 |
1,354 |
267 |
||||||||||
Equity loss (gain) from NEC TOKIN |
— |
— |
— |
1,254 |
1,254 |
||||||||||
Net foreign exchange loss (gain) |
1,789 |
(442) |
(464) |
(911) |
(28) |
||||||||||
Registration related fees |
20 |
— |
— |
— |
20 |
||||||||||
Adjusted EBITDA |
$ |
13,632 |
$ |
17,341 |
$ |
19,647 |
$ |
12,705 |
$ |
63,326 |
Contact:
William M. Lowe, Jr.
Executive Vice President and
Chief Financial Officer
[email protected]
864-963-6484
Richard J. Vatinelle
Director of Finance and
Investor Relations
[email protected]
954-766-2800
SOURCE KEMET Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article